A venture philanthropy fund based in the Western US makes equity investments of varied amounts; significant previous investments have ranged from $1-5 million. The fund invests globally, and will make between 2-3 allocations in the next 6-9 months.
The venture philanthropy group invests primarily in therapeutics to treat a specific orphan disease. However, the fund is open to exploring any therapeutic technology, and has recently invested in small molecule drugs. The fund considers projects are at a range of development stages, from preclinical/drug discovery to Phase II trials for repurposed drugs.
The fund looks for experienced researchers with prior records of success, and projects from both public and private companies are considered.
Next Phase Newsletter 